Compagnie Lombard Odier SCmA’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-50,000
Closed -$448K 900
2016
Q3
$448K Hold
50,000
0.01% 369
2016
Q2
$269K Hold
50,000
0.01% 434
2016
Q1
$230K Hold
50,000
0.01% 466
2015
Q4
$260K Hold
50,000
0.01% 431
2015
Q3
$302K Sell
50,000
-15,000
-23% -$184K 0.01% 352
2015
Q2
$1.03M Sell
65,000
-5,000
-7% -$60.7K 0.04% 221
2015
Q1
$761K Buy
70,000
+20,000
+40% +$204K 0.03% 260
2014
Q4
$526K Buy
50,000
+10,000
+25% +$97.7K 0.02% 255
2014
Q3
$384K Buy
40,000
+6,000
+18% +$61.3K 0.02% 376
2014
Q2
$393K Buy
34,000
+10,000
+42% +$91.1K 0.02% 382
2014
Q1
$240K Buy
24,000
+6,000
+33% +$86.6K 0.01% 469
2013
Q4
$234K Buy
+18,000
New +$248K 0.01% 492

Compagnie Lombard Odier SCmA's RPTP Position: Q4 2016 in Review

Compagnie Lombard Odier SCmA sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 50,000 shares — an estimated $448K sold.

Compagnie Lombard Odier SCmA first reported a position in RPTP in Q4 2013 and held it in 12 quarters. The position peaked at $1.03M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Compagnie Lombard Odier SCmA reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 50,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $448K.
  • Compagnie Lombard Odier SCmA first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 12 quarters.
  • Compagnie Lombard Odier SCmA's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.03M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2016, filed 14 Feb 2017.